Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Beam Therapeutics Inc. (BEAM)

NASDAQ

$23,40

$+0,23

(+1,00%)

Pre-Market

Beam Therapeutics Inc. (BEAM) Live Price Chart

Last updated: ⁦2026-09-16 13:20:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Beam Therapeutics Inc. (BEAM) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $23,40, with a market capitalisation of $2,49B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $20,23 to $38,26. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$2,49B
Open	$23,17
Day's High	$138,52
Day's Low	$13,00
Previous Close	$23,22
Volume	5,58K
Average Volume	2,14M
P/E Ratio	--
52-Week High	$38,26
52-Week Low	$20,23
Dividend Yield	--
Earnings Date	--

Beam Therapeutics Inc. (BEAM) Pre-Market Stock Price

Beam Therapeutics Inc. (BEAM) is trading at $23,40 in pre-market trading as of 2026-09-16 13:15:00, up 0,76% ($0,18) from the previous close of $23,22

Pre-market trading shows how investors are pricing BEAM before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Beam Therapeutics Inc. (BEAM) 7-Day Stock Price Change

Over the past seven days, Beam Therapeutics Inc. (BEAM) moved from $29,66 to $23,40, representing a decline of 21,12% ($6,26).

The stock traded between $22,86 and $29,97 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 2,49 million shares, up versus the previous seven-day period, indicating higher trading activity.

BEAM 52-Week Price Position

Position in Range: 17,6%

52W Low$20,23

52W High$38,26

BEAM is currently trading at $23,40, placing it 17,6% of the way from its 52-week low of $20,23 to its 52-week high of $38,26. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Beam Therapeutics Inc. (BEAM)?

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Beam Therapeutics Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	540
Exchange	NASDAQ
Company Website	https://www.beamtx.com

How to Buy Beam Therapeutics Inc. (BEAM) Stock on MEXC

Eligible investors can buy real shares of Beam Therapeutics Inc. (BEAM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for BEAM and Place Your Order

Open the RealStocks trading page and search for BEAM. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Beam Therapeutics Inc. (BEAM) stock price today?

Beam Therapeutics Inc. (BEAM) is currently trading at $ 23,40, up 0,76% ($0,18) from the previous close of $ 23,22. Intraday prices update in real time during regular trading hours.

2.Is BEAM stock going up or down today?

As of 2026-09-16 13:15:00, BEAM is trading at $ 23,40, up 0,76% ($0,18) from its previous close of $ 23,22. The stock has traded between $ 13,00 and $ 138,52 during today’s regular session. Past price movements do not guarantee future results.

3.What is BEAM pre-market price?

As of 2026-09-16 13:15:00, BEAM is trading at $ 23,40 in pre-market trading, up 0,76% ($0,18) from the previous close of $ 23,22. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is BEAM after-hours price?

As of 2026-09-16 13:15:00, BEAM is trading at $ 23,16 in after-hours trading, down 0,24% ($0,06) from the regular-session close of $ 23,22. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is BEAM stock trading now?

BEAM trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does BEAM sit relative to its 52-week high and low?

Over the past 52 weeks, BEAM has traded between a low of $ 20,23 and a high of $ 38,26. At $ 23,40, the stock is positioned 17,6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Beam Therapeutics Inc. in?

Beam Therapeutics Inc. (BEAM) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Beam Therapeutics Inc.'s market capitalisation and where is it listed?

Beam Therapeutics Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 2,49B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is BEAM valued in terms of P/E ratio and EPS?

BEAM trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0,83. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Beam Therapeutics Inc. pay a dividend?

Beam Therapeutics Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.